Rise Advisors’s AMN Healthcare AMN Stock Holding History

Rise Advisors’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30	Closed	-$2.49K	–	682
2023 Q1	$2.49K	Hold	30	–	–	﹤0.01%	544
2022 Q4	$3.08K	Hold	30	–	–	﹤0.01%	508
2022 Q3	$3K	Hold	30	–	–	﹤0.01%	484
2022 Q2	$3K	Buy	+30	New	+$2.97K	﹤0.01%	490

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rise Advisors's AMN Position: Q2 2023 in Review

Rise Advisors sold out of AMN Healthcare (AMN) in Q2 2023, closing a stake of 30 shares — an estimated $2.49K sold.

Rise Advisors first reported a position in AMN in Q2 2022 and held it in 4 quarters. The position peaked at $3.08K in Q4 2022. 425 funds tracked by Wall St. Rank hold AMN as of Q2 2023.

Rise Advisors reported no remaining AMN Healthcare position as of Q2 2023 after selling out during the quarter.
Rise Advisors sold 30 AMN Healthcare shares in Q2 2023, an estimated $2.49K.
Rise Advisors first reported a position in AMN Healthcare in Q2 2022 and held it in 4 quarters.
Rise Advisors's AMN Healthcare position peaked at $3.08K in Q4 2022.
425 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2023.

Based on Rise Advisors's 13F filing for Q2 2023, filed 10 Jul 2023.